5075 studies found for:    MS
Show Display Options
Rank Status Study
1 Completed A Phase I/II Study of GX15-070MS in Untreated CLL
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: GX15-070MS
2 Recruiting Efficacy of Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of MS After a Clinically Isolated Syndrome
Condition: Multiple Sclerosis
Interventions: Drug: Vitamin D;   Drug: Placebo;   Other: Imaging;   Biological: Lumbar puncture;   Biological: Blood sampling;   Biological: Urine samples
3 Unknown  Evaluation of Quality of Life and Survival With MS-20 in Patient With Advanced Hepatocellular Carcinoma (FDA IND 74572)
Condition: Hepatocellular Carcinoma
Interventions: Drug: MS-20;   Drug: Placebo
4 Completed
Has Results
Oral Cladribine in Early Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Interventions: Drug: Cladribine;   Drug: Placebo;   Drug: Rebif® new formulation (RNF)
5 Recruiting Effect of Vitamin D Replacement on Immune Function and Cognition in MS Patients
Condition: Multiple Sclerosis (MS)
Intervention:
6 Completed Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Intervention: Drug: colecalciferol
7 Unknown  Is MS14 Helpful in Schizophrenia?
Condition: Schizophrenia
Interventions: Drug: MS14;   Drug: Risperidone
8 Recruiting ATX-MS-1467 in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: ATX-MS-1467
9 Completed Bioavailability of BIBR 953 ZW After Oral Administration of BIBR 1048 MS in Healthy Subjects
Condition: Healthy
Interventions: Drug: BIBR 1048 MS Capsule E;   Drug: BIBR 1048 MS Capsule F;   Drug: BIBR 1048 MS Capsule G;   Drug: BIBR 1048 MS Tablet H;   Drug: BIBR 1048 MS Drinking solution;   Drug: Pantoprazole
10 Enrolling by invitation Comparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS)
Condition: Relapsing Remitting Multiple Sclerosis
Intervention:
11 Completed Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations
Condition: Multiple Sclerosis (MS)
Intervention: Drug: H.P. Acthar Gel (repository corticotropin injection)
12 Completed AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS
Conditions: Multiple Sclerosis;   Clinically Isolated Syndrome
Intervention:
13 Completed Bioavailability of BIBR 953 ZW After Administration of BIBR 1048 MS in Healthy Subjects
Condition: Healthy
Interventions: Drug: BIBR 1048 MS Capsule I;   Drug: BIBR 1048 MS Capsule K;   Drug: Pantoprazole;   Drug: BIBR 1048 MS drinking solution
14 Completed Therapy Optimization in Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Intervention: Drug: Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b
15 Completed Safety, Pharmacokinetics and Pharmacodynamics After Single Rising Oral Doses of BIBR 1048 MS as Capsules in Healthy Subjects of Japanese and Caucasian Origin
Condition: Healthy
Interventions: Drug: BIBR 1048 MS;   Drug: Placebo of BIBR 1048 MS
16 Active, not recruiting Using Optical Coherence Tomography to Capture Retinal Microvascular Changes Associated With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
17 Active, not recruiting Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease
Conditions: Multiple Sclerosis (MS);   Relapsing-Remitting MS;   Primary Progressive MS;   Secondary Progressive MS;   Clinically Isolated Syndrome (CIS)
Intervention: Other: No study treatments administered - blood draws only
18 Completed Multiple Oral Doses of BIBR 1048 MS Solution in Healthy Volunteers
Condition: Healthy
Interventions: Drug: BIBR 1048 MS low;   Drug: BIBR 1048 MS medium 1;   Drug: BIBR 1048 MS medium 2;   Drug: BIBR 1048 MS high;   Drug: BIBR 1048 MS placebo
19 Completed Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention: Drug: ONO-2333Ms
20 Completed Pharmacodynamics, Safety and Pharmacokinetics After Oral Administration of BIBR 1048 MS in Healthy Volunteers
Condition: Healthy
Interventions: Drug: BIBR 1048 MS dose 1;   Drug: BIBR 1048 MS dose 2;   Drug: BIBR 1048 MS dose 3;   Drug: BIBR 1048 MS dose 4;   Drug: BIBR 1048 MS dose 5;   Drug: Placebo to BIBR 1048 MS

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years